Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia
Mei Han, Chao Deng
Neuroscience Letters (2018) Vol. 726, pp. 133870-133870
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer
Luca Colucci-D’Amato, Luisa Speranza, Floriana Volpicelli
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7777-7777
Open Access | Times Cited: 643
Brain-derived neurotrophic factor and schizophrenia
Pasquale Di Carlo, Giovanna Punzi, Gianluca Ursini
Psychiatric Genetics (2019) Vol. 29, Iss. 5, pp. 200-210
Open Access | Times Cited: 94
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Rodrigo Nieto, Andrea Carrasco, Sebastián Corral, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 64
Adverse effects of early-life stress: focus on the rodent neuroendocrine system
Seung Hyun Lee, Eui‐Man Jung
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 336-341
Open Access | Times Cited: 26
Radix Bupleuri aqueous extract attenuates MK801-induced schizophrenia-like symptoms in mice: Participation of intestinal flora
Ping Yang, Sheng Huang, Zhihong Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116267-116267
Open Access | Times Cited: 8
Probiotics supplementation and brain-derived neurotrophic factor (BDNF): a systematic review and meta-analysis of randomized controlled trials
Fereshteh Dehghani, Shima Abdollahi, Farzad Shidfar, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 10, pp. 942-952
Closed Access | Times Cited: 30
Containment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice
Benneth Ben‐Azu, Olusegun G. Adebayo, Aliance Romain Fokoua, et al.
Brain Disorders (2024) Vol. 13, pp. 100122-100122
Open Access | Times Cited: 7
Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects
Laura Orsolini, Simone Pompili, Umberto Volpe
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5040-5040
Open Access | Times Cited: 24
NMDA receptor modulation by Esculetin: Investigating behavioral, biochemical and neurochemical effects in schizophrenic mice model
Iqra Khalid, Uzma Saleem, Bashir Ahmad, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 4, pp. 101994-101994
Open Access | Times Cited: 5
Biomarkers of endogenous mental disorders: the role of cortisol, extracellular DNA, BDNF, and cytokines in relation to disease stage and therapy
M. V. Kuzminova, Е. В. Семина, Y. A. Chayka
Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) (2025), Iss. 2, pp. 245-258
Closed Access
Lactobacillus Johnsonii YH1136 alleviates schizophrenia-like behavior in mice: a gut–microbiota–brain axis hypothesis study
Liqin Zheng, Jinge Xin, Huiqian Ye, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions
Rozaziana Ahmad, Khairunnuur Fairuz Azman, Rosliza Yahaya, et al.
AIMS neuroscience (2023) Vol. 10, Iss. 1, pp. 5-32
Open Access | Times Cited: 8
Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry for Simultaneous Determination of Antipsychotic Drugs in Human Plasma and Its Application in Therapeutic Drug Monitoring
Yingjie Qi, Guangxuan Liu
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 463-479
Open Access | Times Cited: 19
Contributions of epigenetic inheritance to the predisposition of major psychiatric disorders: Theoretical framework, evidence, and implications
Roger B. Varela, José H. Cararo, Susannah J. Tye, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 135, pp. 104579-104579
Open Access | Times Cited: 13
Introducing the Neuroplastic Narrative: a non-pathologizing biological foundation for trauma-informed and adverse childhood experience aware approaches
Haley Peckham
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 7
Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes
Ye Lv, Lin Wen, Wen-Juan Hu, et al.
Metabolic Brain Disease (2023) Vol. 39, Iss. 1, pp. 147-171
Closed Access | Times Cited: 7
Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions
Luana M. Manosso, Jaime Lin, Anelise S. Carlessi, et al.
Brain Research Bulletin (2021) Vol. 171, pp. 196-208
Closed Access | Times Cited: 17
Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
John L. Waddington, Xuechu Zhen, Colm O’Tuathaigh
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 16
Reversible Changes in BDNF Expression in MK-801-Induced Hippocampal Astrocytes Through NMDAR/PI3K/ERK Signaling
Wenjuan Yu, Hongwei Fang, Lei Zhang, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
Lactobacillus rhamnosus GG and Bifidobacterium bifidum TMC3115 Can Affect Development of Hippocampal Neurons Cultured In Vitro in a Strain-Dependent Manner
Ruyue Cheng, Tong Xu, Yujie Zhang, et al.
Probiotics and Antimicrobial Proteins (2019) Vol. 12, Iss. 2, pp. 589-599
Closed Access | Times Cited: 15
A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia
Егор Чумаков, Мария Дорофейкова, Kristina Tsyrenova, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 8
Effects of brain-derived neurotrophic factor and adeno-associated viral vector on morphine-induced condition through target concentration changes in the ventral tegmental area and nucleus accumbens
Lisha Deng, Zheng Chu, Peng Liu, et al.
Behavioural Brain Research (2023) Vol. 445, pp. 114385-114385
Closed Access | Times Cited: 4
IUPHAR Themed Review: The Gut Microbiome in Schizophrenia
Srinivas Kamath, Elysia Sokolenko, Kate Collins, et al.
Pharmacological Research (2024), pp. 107561-107561
Open Access | Times Cited: 1
Pharmacogenetics of Antipsychotic Treatment in Schizophrenia
Samar S. M. Elsheikh, Daniel J. Müller, Jennie G. Pouget
Methods in molecular biology (2022), pp. 389-425
Closed Access | Times Cited: 7
Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis
Núria Pujol, Anna Mané, Daniel Bergé, et al.
Schizophrenia Research (2020) Vol. 223, pp. 345-352
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top